XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Changes in Series A Preferred Stock and Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Series A Preferred Stock [Member]
Balance at Dec. 31, 2023         $ 0
Balance (in shares) at Dec. 31, 2023         0
Balance at Mar. 31, 2024         $ 0
Balance (in shares) at Mar. 31, 2024         0
Balance at Dec. 31, 2023 $ 2 $ 131,370 $ (81,466) $ 49,906  
Balance (in shares) at Dec. 31, 2023 23,977,491        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in connection with the at-the-market program and purchase agreement $ 1 2,478 0 2,479  
Issuance of common stock in connection with the at-the-market program and purchase agreement (in shares) 1,000,550        
Issuance costs $ 0 (165) 0 (165)  
Stock-based compensation $ 0 985 0 985  
Stock-based compensation (in shares) 120,516        
Share repurchases for the payment of employee taxes $ 0 (42) 0 (42)  
Share repurchases for the payment of employee taxes (in shares) (12,965)        
Net and comprehensive loss $ 0 0 (7,106) (7,106)  
Balance at Mar. 31, 2024 $ 3 134,626 (88,572) 46,057  
Balance (in shares) at Mar. 31, 2024 25,085,592        
Balance at Dec. 31, 2023         $ 0
Balance (in shares) at Dec. 31, 2023         0
Balance at Sep. 30, 2024         $ 0
Balance (in shares) at Sep. 30, 2024         0
Balance at Dec. 31, 2023 $ 2 131,370 (81,466) 49,906  
Balance (in shares) at Dec. 31, 2023 23,977,491        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net and comprehensive loss       (22,397)  
Balance at Sep. 30, 2024 $ 3 138,160 (103,863) 34,300  
Balance (in shares) at Sep. 30, 2024 26,198,444        
Balance at Mar. 31, 2024         $ 0
Balance (in shares) at Mar. 31, 2024         0
Balance at Jun. 30, 2024         $ 0
Balance (in shares) at Jun. 30, 2024         0
Balance at Mar. 31, 2024 $ 3 134,626 (88,572) 46,057  
Balance (in shares) at Mar. 31, 2024 25,085,592        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in connection with the at-the-market program and purchase agreement $ 0 1,563 0 1,563  
Issuance of common stock in connection with the at-the-market program and purchase agreement (in shares) 788,566        
Issuance costs $ 0 (25) 0 (25)  
Stock-based compensation $ 0 806 0 806  
Stock-based compensation (in shares) 104,880        
Net and comprehensive loss $ 0 0 (7,765) (7,765)  
Balance at Jun. 30, 2024 $ 3 136,970 (96,337) 40,636  
Balance (in shares) at Jun. 30, 2024 25,979,038        
Balance at Sep. 30, 2024         $ 0
Balance (in shares) at Sep. 30, 2024         0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in connection with the at-the-market program and purchase agreement $ 0 456 0 456  
Issuance of common stock in connection with the at-the-market program and purchase agreement (in shares) 219,406        
Issuance costs $ 0 (42) 0 (42)  
Stock-based compensation $ 0 776 0 776  
Stock-based compensation (in shares) 0        
Net and comprehensive loss $ 0 0 (7,526) (7,526)  
Balance at Sep. 30, 2024 $ 3 138,160 (103,863) 34,300  
Balance (in shares) at Sep. 30, 2024 26,198,444        
Balance at Dec. 31, 2024       18,843 $ 18,843
Balance (in shares) at Dec. 31, 2024         14,145.374
Balance at Mar. 31, 2025         $ 18,843
Balance (in shares) at Mar. 31, 2025         14,145.374
Balance at Dec. 31, 2024 $ 3 145,719 (138,998) 6,724  
Balance (in shares) at Dec. 31, 2024 31,574,657        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock and pre-funded warrants in connection with the March 2025 offering and private placement $ 1 5,979 0 5,980  
Issuance of common stock and pre-funded warrants in connection with the March 2025 offering and private placement (in shares) 13,396,207        
Issuance of common stock in connection with the at-the-market program and purchase agreement $ 1 408 0 409  
Issuance of common stock in connection with the at-the-market program and purchase agreement (in shares) 352,953        
Issuance costs $ 0 (728) 0 (728)  
Stock-based compensation $ 0 913 0 913  
Stock-based compensation (in shares) 186,919        
Share repurchases for the payment of employee taxes $ 0 (36) 0 (36)  
Share repurchases for the payment of employee taxes (in shares) (31,913)        
Exercise of stock options $ 0 5 0 5  
Exercise of stock options (in shares) 5,000        
Net and comprehensive loss $ 0 0 (8,194) (8,194)  
Balance at Mar. 31, 2025 $ 5 152,260 (147,192) 5,073  
Balance (in shares) at Mar. 31, 2025 45,483,823        
Balance at Dec. 31, 2024       18,843 $ 18,843
Balance (in shares) at Dec. 31, 2024         14,145.374
Balance at Sep. 30, 2025       0 $ 0
Balance (in shares) at Sep. 30, 2025         0
Balance at Dec. 31, 2024 $ 3 145,719 (138,998) 6,724  
Balance (in shares) at Dec. 31, 2024 31,574,657        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net and comprehensive loss       (33,068)  
Balance at Sep. 30, 2025 $ 6 178,027 (172,066) 5,967  
Balance (in shares) at Sep. 30, 2025 64,544,096        
Balance at Mar. 31, 2025         $ 18,843
Balance (in shares) at Mar. 31, 2025         14,145.374
Balance at Jun. 30, 2025         $ 0
Balance (in shares) at Jun. 30, 2025         0
Balance at Mar. 31, 2025 $ 5 152,260 (147,192) 5,073  
Balance (in shares) at Mar. 31, 2025 45,483,823        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Conversion of preferred stock         $ (18,843)
Conversion of preferred stock (in shares)         (14,145.374)
Conversion of preferred stock $ 1 18,842 0 18,843  
Conversion of preferred stock (in shares) 14,145,374        
Issuance costs $ 0 81 0 81  
Stock-based compensation $ 0 896 0 896  
Stock-based compensation (in shares) 278,858        
Net and comprehensive loss $ 0 0 (7,420) (7,420)  
Balance at Jun. 30, 2025 $ 6 172,079 (154,612) 17,473  
Balance (in shares) at Jun. 30, 2025 59,908,055        
Balance at Sep. 30, 2025       0 $ 0
Balance (in shares) at Sep. 30, 2025         0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in connection with the at-the-market program and purchase agreement $ 0 5,217 0 5,217  
Issuance of common stock in connection with the at-the-market program and purchase agreement (in shares) 4,611,041        
Issuance costs $ 0 (107) 0 (107)  
Stock-based compensation $ 0 816 0 816  
Stock-based compensation (in shares) 0        
Exercise of stock options $ 0 22 0 22  
Exercise of stock options (in shares) 25,000        
Net and comprehensive loss $ 0 0 (17,454) (17,454)  
Balance at Sep. 30, 2025 $ 6 $ 178,027 $ (172,066) $ 5,967  
Balance (in shares) at Sep. 30, 2025 64,544,096